The US Food and Drug Administration has approved a new drug for the treatment of thrombocytopenia in adults with chronic liver disease scheduled to undergo a procedure.
In a study of data from 2009 to 2013, researchers assessed incidence and complication rates, outcomes, and disease burden of heparin-induced thrombocytopenia in the United States.
In a study of data from 2009 to 2013, researchers assessed incidence and complication rates, outcomes, and disease burden of heparin-induced thrombocytopenia in the United States.
After reviewing data from 2 randomized placebo-controlled Phase 3 trials and an open-label extension, the FDA has approved a new option for the treatment of adults with chronic immune thrombocytopenia.
...
In a recent study, researchers sought to examine trends of splenectomy in hospitalizations with ITP, and the factors associated with splenectomy during these encounters.
In a recent study, researchers sought to examine trends of splenectomy in hospitalizations with ITP, and the factors associated with splenectomy during these encounters.
It is currently unclear how to best screen populations at risk for multiple myeloma and evaluate the potential effectiveness of early interventions. Using a computational model, researchers investigated...
In a recent analysis of the Framingham Heart Study Original Cohort, researchers assessed 1252 individuals in order to determine whether there exists a common threshold level above which blood pressure rise...
In a new study of 57,058 individuals, researchers examined the relationship between common pain medications and the risk of cardiovascular complications.
